On Wednesday, March 15, the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) Coalition hosted a one-hour webinar on symptomatic relief for Alzheimer’s disease. The webinar featured leading experts who discussed the burden of Alzheimer’s disease on patients and their families. They also highlighted advances in neurobiology and provided updates on clinical development activities to improve the treatment of Alzheimer’s-related symptoms.
The webinar’s featured experts were:
Jeffrey L. Cummings, M.D., Sc.D., Director, Lou Ruvo Center for Brain Health, Camille and Larry Ruvo Chair for Brain Health, Cleveland Clinic
Richard Malamut, M.D., Chief Medical Officer, Senior Vice President, Research & Development, Avanir Pharmaceuticals
Joan Amatniek, M.D., Msc, Senior Director, CNS, Global Clinical Development, Otsuka Pharmaceutical
Cynthia A. Bens, Executive Director, Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD)
